Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease

Journal of Psychiatry and Neuroscience

Volumn 22, Issue 5, 1997, Pages 303-317

  McDonald, Michael P ^a   Crawley, Jacqueline N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; GALANIN; NEUROPEPTIDE; RECEPTOR BLOCKING AGENT;

ACETYLCHOLINE RELEASE; AGING; ALZHEIMER DISEASE; ANIMAL MODEL; BRAIN DISEASE; COGNITIVE DEFECT; DEGENERATIVE DISEASE; LEARNING; MEMORY; NERVE CELL PLASTICITY; NONHUMAN; PROTEIN EXPRESSION; RAT; REVIEW;

ACETYLCHOLINE; ALZHEIMER DISEASE; ANIMALS; CHOLINERGIC ANTAGONISTS; GALANIN; HUMANS; MEMORY; RATS;

EID: 0031454983     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (246)

1. Tatemoto K, Rökaeus A, Jornvall H, McDonald TJ, Mutt V. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett 1983;164:124-8.
2. Rökaeus Å, Melander T, Hökfelt T, Lundberg JM, Tatemoto K, Carlquist M, et al. A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci Lett 1984;47:161-6.
3. Cheung A, Polak JM, Bauer FE, Cadieux A, Christofides ND, Springall DR, et al. Distribution of galanin immunoreactivity in the respiratory tract of pig, guinea pig, rat, and dog. Thorax 1985;40:889-96.
4. Ch'ng JL, Christofides ND, Anand P, Gibson SJ, Allen YS, Su HC, et al. Distribution of galanin immunoreactivity in the central nervous system and the responses of galanin-containing neuronal pathways to injury. Neuroscience 1985;16:343-54.
5. Ekblad E, Håkanson R, Sundler F, Wahlestedt C. Galanin: neuromodulatory and direct contractile effects on smooth muscle preparations. Br J Pharmacol 1985;86:241-6.
6. Bauer FE, Adrian TE, Christofides ND, Ferri GL, Yanaihara N, Polak JM, et al. Distribution and molecular heterogeneity of galanin in human, pig, guinea pig, and rat gastrointestinal tracts. Gastroenterology 1986;91:877-83.
7. Melander T, Hökfelt T, Rökaeus Å, Fahrenkrug J, Tatemoto K, Mutt V. Distribution of galanin-like immunoreactivity in the gastro-intestinal tract of several mammalian species. Cell Tissue Res 1985;239:253-70.
8. Ghatei MA, Springall DR, Richards IM, Oostveen JA, Griffin RL, Cadieux A, et al. Regulatory peptides in the respiratory tract of Macaca fascicularis. Thorax 1987;42:431-9.
9. Rökaeus Å. Galanin: a new isolated biologically active neuropeptide. Trends Neurosci 1987;10:158-64.
10. King SC, Slater P, Turnberg LA. Autoradiographic localization of binding sites for galanin and VIP in small intestine. Peptides 1989;10:313-7.
11. Skofitsch G, Jacobowitz DM. Galanin-like immunoreactivity in capsaicin sensitive sensory neurons and ganglia. Brain Res Bull 1985;15:191-5.
12. Polak JM, Bloom SR. Regulatory peptides of the gastrointestinal and respiratory tracts. Arch Int Pharmacodyn Ther 1986;280:16-49.
13. Konopka LM, McKeon TW, Parsons RL. Galanin-induced hyperpolarization and decreased membrane excitability of neurones in mudpuppy cardiac ganglia. J Physiol (Lond) 1989;410:107-22.
14. Konopka LM, Merriam LA, Hardwick JC, Parsons RL. Aminergic and peptidergic elements and actions in a cardiac parasympathetic ganglion. Can J Physiol Pharmacol 1992;70 (suppl):S32-43.
15. Ahrén B, Bottcher G, Kowalyk S, Dunning BE, Sundler F, Taborsky GJ. Galanin is co-localized with noradrenaline and neuropeptide Y in dog pancreas and celiac ganglion. Cell Tissue Res 1990;261:49-58.
16. McKeon TW, Parsons RL. Galanin immunoreactivity in the mudpuppy cardiac ganglion. J Auton Nerv Syst 1990;31:135-40.
17. Parsons RL, Neel DS, Konopka LM, McKeon TW. The presence and possible role of a galanin-like peptide in the mudpuppy heart. Neuroscience 1989;29:749-59.
18. O'Halloran DJ, Jones PM, Bloom SR. Neuropeptides synthesised in the anterior pituitary: possible paracrine role. Mol Cell Endocrinol 1991;75:C7-12.
19. Parsons RL, Konopka LM. Analysis of the galanin-induced decrease in membrane excitability in mudpuppy parasympathetic neurons. Neuroscience 1991;43:647-60.
20. Hökfelt T, Bartfai T, Ceccatelli S, Cortes R, Fisone G, Gulting A-L, et al. Central and sensory galanin neurons and functional aspects. Biomed Res 1992;13:311-7.
21. Parsons RL, Merriam LA. Galanin and bethanechol appear to activate the same inwardly rectifying potassium current in mudpuppy parasympathetic neurons. Neurosci Lett 1992;140:33-6.
22. Ulman LG, Potter EK, McCloskey DI. Effects of sympathetic activity and galanin on cardiac vagal action in anaesthetized cats. J Physiol (Lond) 1992;448:225-35.
23. Ulman LG, Moriarty M, Potter EK, McCloskey DI. Galanin antagonist effects on cardiac vagal inhibitory actions of sympathetic stimulation in anaesthetized cats and dogs. J Physiol (Lond) 1993;464:491-9.
24. Ulman LG, Potter EK, McCloskey DI. Functional effects of a family of galanin antagonists on the cardiovascular system in anaesthetised cats. Regul Pept 1994;51:17-23.
25. Zhu W, Dey RD. Distribution of the neuropeptide galanin in the cat heart and coexistence with vasoactive intestinal peptide, substance P and neuropeptide Y. J Mol Cell Cardiol 1992;24:35-41.
26. el-Salhy M, Stenling R, Grimelius L. Peptidergic innervation and endocrine cells in the human liver. Scand J Gastroenterol 1993;28:809-15.
27. Longley CD, Weaver LC. Proportions of renal and splenic postganglionic sympathetic populations containing galanin and dopamine beta hydroxylase. Neuroscience 1993;55:253-61.
28. Elfvin LG, Hökfelt T, Bartfai T, Bedecs K. Immunohistochemical demonstration of galanin-, and galanin message-associated peptide-like immunoreactivities in sympathetic ganglia and adrenal gland of the guinea pig. Microsc Res Tech 1994;29:131-42.
29. Wang YF, Mao YK, McDonald TJ, Daniel EE. Distribution of galanin-immunoreactive nerves in the canine gastrointestinal tract. Peptides 1995;16:237-47.
30. Skofitsch G, Jacobowitz DM. Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides 1985;6:509-46.
31. 125I-galanin binding sites in the rat central nervous system. Peptides 1986;7:1029-42.
32. Steel JH, Gon G, O'Halloran DJ, Jones PM, Yanaihara N, Ishikawa H, et al. Galanin and vasoactive intestinal polypeptide are colocalised with classical pituitary hormones and show plasticity of expression. Histochemistry 1989;93:183-9.
33. Hyde JF, Keller BK. Galanin secretion from anterior pituitary cells in vitro is regulated by dopamine, somatostatin, and thyrotropin-releasing hormone. Endocrinology 1991;128:917-22.
34. Hyde JF, Howard G. Regulation of galanin gene expression in the rat anterior pituitary gland by the somatostatin analog SMS 201-995. Endocrinology 1992;131:2097-102.
35. Hyde JF, Morrison DG, Moore JP Jr, Howard G. MtTW-10 pituitary tumor cells: galanin gene expression and peptide secretion. Endocrinology 1993;133:2588-93.
36. Niimi M, Murao K, Takahara J, Kawanishi K. Identification of galanin-immunoreactive cells in the anterior pituitary of male monkeys. Macaca fascicularis. Endocr J 1993;40:231-5.
37. Wynick D, Smith DM, Ghatei M, Akinsanya K, Bhogal R, Purkiss P, et al. Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor. Proc Natl Acad Sci U S A 1993;90:4231-5.
38. Skofitsch G, Jacobowitz DM. Quantitative distribution of galanin-like immunoreactivity in the rat central nervous system. Peptides 1986;7:609-13.
39. Melander T, Staines WA, Hökfelt T, Rökaeus Å, Eckenstein F, Salvaterra PM, et al. Galanin-like immunoreactivity in cholinergic neurons of the septum-basal forebrain complex projecting to the hippocampus of the rat. Brain Res 1985;360:130-8.
40. Melander T, Hökfelt T, Rökaeus Å. Distribution of galaninlike immunoreactivity in the rat central nervous system. J Comp Neurol 1986;248:475-517.
41. Melander T, Fuxe K, Harfstrand A, Eneroth P, Hökfelt T. Effects of intraventricular injections of galanin on neuroendocrine functions in the male rat: possible involvement of hypothalamic catecholamine neuronal systems. Acta Physiol Scand 1987;131:25-32.
42. Merchenthaler I, Lopez FJ, Negro-Vilar A. Anatomy and physiology of central galanin-containing pathways. Prog Neurobiol 1993;40:711-69.
43. Beal MF, Gabriel SM, Swartz KJ, MacGarvey UM. Distribution of galanin-like immunoreactivity in baboon brain. Peptides 1988;9:847-51.
44. Chan-Palay V. Neurons with galanin innervate cholinergic cells in the human basal forebrain and galanin and acetylcholine coexist. Brain Res Bull 1988;21:465-72.
45. Gentleman SM, Falkai P, Bogerts B, Herrero MT, Polak JM, Roberts GW. Distribution of galanin-like immunoreactivity in the human brain. Brain Res 1989;505:311-5.
46. Kowall NW, Beal MF. Galanin-like immunoreactivity is present in human substantia innominata and in senile plaques in Alzheimer's disease. Neurosci Lett 1989;98:118-23.
47. Gai WP, Geffen LB, Blessing WW. Galanin immunoreactive neurons in the human hypothalamus: colocalization with vasopressin-containing neurons. J Comp Neurol 1990;298:265-80.
48. Kordower JH, Mufson EJ. Galanin-like immunoreactivity within the primate basal forebrain: differential staining patterns between humans and monkeys. J Comp Neurol 1990;294:281-92.
49. Kordower JH, Le HK, Mufson EJ. Galanin immunoreactivity in the primate central nervous system. J Comp Neurol 1992;319:479-500.
50. Bowser, R, Kordower, JH, Mufson EJ. A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease. Brain Pathol 1997;2:723-30.
51. Melander T, Hökfelt T, Rökaeus Å, Cuello AC, Oertel WH, Verhofstad A, et al. Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J Neurosci 1986;6:3640-54.
52. Levin MC, Sawchenko PE, Howe PR, Bloom SR, Polak JM. Organization of galanin-immunoreactive inputs to the paraventricular nucleus with special reference to their relationship to catecholaminergic afferents. J Comp Neurol 1987;261:562-82.
53. Nordström Ö, Melander T, Hökfelt T, Bartfai T, Goldstein M. Evidence for an inhibitory effect of the peptide galanin on dopamine release from the rat median eminence. Neurosci Lett 1987;73:21-6.
54. Holets VR, Hökfelt T, Rökaeus Å, Terenius L, Goldstein M. Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus. Neuroscience 1988;24:893-906.
55. Moore RY, Gustafson EL. The distribution of dopamine-ß-hydroxylase, neuropeptide Y and galanin in locus coeruleus neurons. J Chem Neuroanat 1989;2:95-106.
56. Rökaeus Å, Young WS, Mezey E. Galanin coexists with vasopressin in the normal rat hypothalamus and galanin's synthesis is increased in the Brattleboro (diabetes insipidus) rat. Neurosci Lett 1988;90:45-50.
57. Skofitsch G, Jacobowitz DM, Amann R, Lembeck F. Galanin and vasopressin coexist in the rat hypothalamo-neurohypophyseal system. Neuroendocrinology 1989;49:419-27.
58. Planas B, Kolb PE, Raskind MA, Miller MA. Vasopressin and galanin mRNAs coexist in the nucleus of the horizontal diagonal band: a novel site of vasopressin gene expression. J Comp Neurol 1995;361:48-56.
59. Meister B, Scanlon MF, Hökfelt T. Occurrence of galanin-like immunoreactivity in growth hormone-releasing factor (GRF)-containing neurons of the monkey (Macaca fascicularis) infundibular nucleus and median eminence. Neurosci Lett 1990;119:136-9.
60. Melander T, Staines WA. A galanin-like peptide coexists in putative cholinergic somata of the septum-basal forebrain complex and in acetylcholinesterase-containing fibers and varicosities within the hippocampus in the owl monkey. Aotus trivirgatus. Neurosci Lett 1986;68:17-22.
61. Walker LC, Koliatsos VE, Kitt CA, Richardson RT, Rökaeus Å, Price DL. Peptidergic neurons in the basal forebrain magnocellular complex of the rhesus monkey. J Comp Neurol 1989;280:272-82.
62. Benzing WC, Kordower JH, Mufson EJ. Galanin immunoreactivity within the primate basal forebrain: evolutionary change between monkeys and apes. J Comp Neurol 1993;336:31-9.
63. Melander T, Hökfelt T, Nilsson S, Brodin E. Visualization of galanin binding sites in the rat central nervous system. Eur J Pharmacol 1986;124:381-2.
64. 125I-galanin binding sites in the rat central nervous system. J Chem Neuroanat 1988;1:213-33.
65. Hedlund PB, Yanaihara N, Fuxe K. Evidence for specific Nterminal galanin fragment binding sites in the rat brain. Eur J Pharmacol 1992;224:203-5.
66. Köhler C, Hallman H, Melander T, Hökfelt T, Norheim E. Autoradiographic mapping of galanin receptors in the monkey brain. J Chem Neuroanat 1989;2:269-84.
67. Köhler C, Persson A, Melander T, Theodorsson E, Sedvall G, Hökfelt T. Distribution of galanin-binding sites in the monkey and human telencephalon: preliminary observations. Exp Brain Res 1989;75:375-80.
68. Rosier AM, Vandesande F, Orban GA. Laminar and regional distribution of galanin binding sites in cat and monkey visual cortex determined by in vitro receptor autoradiography. J Comp Neurol 1991;305:264-72.
69. Bonnefond C, Palacios JM, Probst A, Mengod G Distribution of galanin mRNA containing cells and galanin receptor binding sites in human and rat hypothalamus. Eur J Neurosci 1990;2:629-37.
70. 125I-galanin binding sites using the method of in vitro receptor autoradiography. Neurosci Lett 1990;120:179-82.
71. Habert-Ortoli E, Amiranoff B, Loquet I, Laburthe M, Mayaux JF. Molecular cloning of a functional human galanin receptor. Proc Natl Acad Sci U S A 1994;91:9780-3.
72. Burgevin MC, Loquet I, Quarteronet D, Habert-Ortoli E. Cloning, pharmacological characterization, and anatomical distribution of a rat cDNA encoding for a galanin receptor. J Mol Neurosci 1995;6:33-41.
73. Grafstein-Dunn E, Cadd GG, Clifton DK, Steiner RA. A rat galanin receptor: its cloning and distribution in rat forebrain. Abstr Soc Neurosci 1995;21:1117.
74. Jasper MS, Bhat N, Kaplan LM. Molecular cloning and expression of the rat type I galanin receptor. Abstr Soc Neurosci 1995;21:1013.
75. Parker EM, Izzarelli DG, Nowak HP, Mahle CD, Iben LG, Wang J, et al. Cloning and characterization of the rat GALR1 galanin receptor from Rin14B insulinoma cells. Brain Res Mol Brain Res 1995;34:179-89.
76. Forray C, Smith K, Gerald C, Vaysse PJ-J, Weinshank R, Branchek T. Pharmacological characterization of the recombinant human and rat GALR1 galanin receptor. Abstr Soc Neurosci 1996;22:1304.
77. Gustafson EL, Smith KE, Durkin MM, Gerald C, Branchek TA. Distribution of a rat galanin receptor mRNA in rat brain. Neuroreport 1996;7:953-7.
78. Sullivan, KA, Shiao LL, Cascieri MA. Pharmacological characterization and tissue distribution of the human and rat GALR1 receptors. Biochem Biophys Res Commun 1997;233:823-8.
79. Ahmad S, Shen SH, Walker P, Wahlestedt C. Identification and molecular cloning of a novel galanin receptor (GALR-2) in rat sensory neurons. Abstr Soc Neurosci 1996;22:1682.
80. O'Donnell D, Ahmad S, Walker P, Wahlestedt C. Neuroanatomical distribution of a novel rat galanin receptor subtype. Abstr Soc Neurosci 1996;22:1304.
81. Howard AD, Tan C, Shiao L-L, Palyha OC, McKee KK, Weinberg DH, et al. Molecular cloning and characterization of a new receptor for galanin. FEBS Lett 1997;405:285-90.
82. Wang S, Hashemi T, He C, Strader C, Bayne M. Molecular cloning and pharmacological characterization of a new galanin receptor subtype. Mol Pharmacol. In press.
83. Bartfai T, Langel Ü, Bedecs K, Andell S, Land T, Gregersen S, et al. Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Proc Natl Acad Sci U S A 90:1993;11287-91.
84. 125I]galanride. J Pharmacol Exp Ther 1995;275:720-7.
85. Kask K, Berthold M, Bartfai T. Galanin receptors - involvement in feeding, pain, depression, and Alzheimer's disease. Life Sci 1997;60:1523-33.
86. Bartfai T, Hökfelt T, Langel Ü. Galanin - a neuroendocrine peptide. Crit Rev Neurobiol 1993;7:229-74.
87. Bedecs K, Berthold M, Bartfai T. Galanin - 10 years with a neuroendocrine peptide. Int J Biochem Cell Biol 1995;27:337-49.
88. Kask K, Langel Ü, Bartfai T. Galanin - a neuropeptide with inhibitory actions. Cell Mol Neurobiol 1995;15:653-73.
89. Gregersen S, Langel Ü, Bartfai T, Ahrén B. N-terminally elongated fragments of galanin(1-16) inhibit insulin secretion from isolated mouse islets. Regul Pept 1994;53:31-7.
90. Lindskog S, Ahrén B, Land T, Langel Ü, Bartfai T. The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion. Eur J Pharmacol 1992;210:183-8.
91. Lindskog S, Gregersen S, Hermansen K, Ahrén B. Effects of galanin on proinsulin mRNA and insulin biosynthesis in normal islets. Regul Pept 1995;58:135-9.
92. Lindskog S, Ahrén B. Effects of galanin and norepinephrine on insulin secretion in the mouse. Pancreas 1992;7:636-41.
93. Fox JE, McDonald TJ, Kostolanska F, Tatemoto K. Galanin: an inhibitory neural peptide of the canine small intestine. Life Sci 1986;39:103-10.
94. Sethi T, Rozengurt E. Galanin stimulates Ca2+ mobilization, inositol phosphate accumulation, and clonal growth in small cell lung cancer cells. Cancer Res 1991;51:1674-9.
95. Sethi T, Rozengurt E. Multiple neuropeptides stimulate clonal growth of small cell lung cancer: effects of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin. Cancer Res 1991;51:3621-3.
96. Hulting AL, Land T, Berthold M, Langel Ü, Hökfelt T, Bartfai T. Galanin receptors from human pituitary tumors assayed with human galanin as ligand. Brain Res 1993;625:173-6.
97. Gregg DW, Galkin M, Gorski J. Effect of estrogen on the expression of galanin messenger-RNA in pituitary tumor-sensitive and tumor-resistant rat strains. Steroids 1996;61:468-72.
98. Iishi H, Tatsuta M, Baba M, Uehara H, Yano H, Nakaizumi A. Chemoprevention by galanin against colon carcinogenesis induced by azoxymethane in Wistar rats, Int J Cancer 1995:61:861-3.
99. Post C, Alari L, Hökfelt T. Intrathecal galanin increases the latency in the tail-flick and hot-plate test in mouse. Acta Physiol Scand 1988;132:583-4.
100. Villar MJ, Cortes R, Theodorsson E, Wiesenfeld-Hallin Z, Schalling M, Fahrenkrug J, et al. Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin. Neuroscience 1989;33:587-604.
101. Wiesenfeld-Hallin Z, Xu XJ, Hughes J, Horwell DC, Hökfelt T. PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes. Proc Natl Acad Sci U S A 1990;87(18):7105-9.
102. Wiesenfeld-Hallin Z, Xu XJ, Villar MJ, Hökfelt T. Intrathecal galanin potentiates the spinal analgesic effect of morphine: electrophysiological and behavioural studies. Neurosci Lett 1990:109:217-21.
103. Wiesenfeld-Hallin Z, Xu XJ, Hughes J, Horwell DC, Hökfelt T. Studies on the effect of systemic PD134308 (CAM 958) in spinal reflex and pain models with special reference to interaction with morphine and intrathecal galanin. Neuropeptides 1991:19:79-84.
104. Wiesenfeld-Hallin Z, Bartfai T, Hökfelt T. Galanin in sensory neurons in the spinal cord. Front Neuroendocrinol 1992:13:319-43.
105. Wiesenfeld-Hallin Z, Xu XJ, Hao JX, Hökfelt T. The behavioural effects of intrathecal galanin on tests of thermal and mechanical nociception in the rat. Acta Physiol Scand 1993:147:457-8.
106. Xu XJ, Wiesenfeld-Hallin Z, Fisone G, Bartfai T, Hökfelt T. The N-terminal 1-16, but not C-terminal 17-29, galanin fragment affects the flexor reflex in rats. Eur J Pharmacol 1990;182:137-41.
107. Xu XJ, Andell S, Hao JX, Wiesenfeld-Hallin Z, Bartfai T. The effects of intrathecal galanin message-associated peptide (GMAP) on the flexor reflex in rats. Regul Pept 1995;58:19-24.
108. Xu XJ, Wiesenfeld-Hallin Z, Langel Ü, Bedecs K, Bartfai T. New high affinity peptide antagonists to the spinal galanin receptor. Br J Pharmacol 1995b:116:2076-80.
109. Murakami Y, Kato Y, Koshiyama H, Inoue T, Yanaihara N, Imura H. Galanin stimulates growth hormone (GH) secretion via GH-releasing factor (GRF) in conscious rats. Eur J Pharmacol 1987;136:415-8.
110. Murakami Y, Ohshima K, Mochizuki T, Yanaihara N. Effect of human galanin on growth hormone prolactin, and antidiuretic hormone secretion in normal men. J Clin Endocrinol Metab 1993;77:1436-8.
111. Hulting AL, Meister B, Carlsson L, Hilding A, Isaksson O. On the role of the peptide galanin in regulation of growth hormone secretion. Acta Endocrinol (Copenh) 1991;125:518-25.
112. Tanoh T, Shimatsu A, Ishikawa Y, Ihara C, Yanaihara N, Imura H. Galanin-induced growth hormone secretion in conscious rats: evidence for a possible involvement of somatostatin. J Neuroendocrinol 1993;5:183-7.
113. Holst JJ, Bersani M, Hvidberg A, Knigge U, Christiansen E, Madsbad S, et al. On the effects of human galanin in man. Diabetologia 1993;36:653-7.
114. Bauer FE, Ginsberg L, Venetikou M, MacKay DJ, Burrin JM, Bloom SR. Growth hormone release in man induced by galanin, a new hypothalamic peptide. Lancet 1986;2:192-5.
115. Carey DG, Iismaa TP, Ho KY, Rajkovic IA, Kelly J, Kraegen EW, et al. Potent effects of human galanin in man: growth hormone secretion and vagal blockade. J Clin Endocrinol Metab 1993;77:90-3.
116. Arvat E, Gianotti L, Ramunni J, Grottoli S, Brossa PC, Bertagna A, et al. Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humans. Eur J Endocrinol 1995;133:300-4.
117. Ögren SO, Pramanik A. Galanin stimulates acetylcholine release in the rat striatum. Neurosci Lett 1991;128:253-6.
118. Pramanik A, Ögren SO. Galanin-evoked acetylcholine release in the rat striatum is blocked by the putative galanin antagonist M15. Brain Res 1992;574:317-9.
119. Amoroso D, Girotti P, Fisone G, Bartfai T, Consolo S. Mechanism of the galanin induced increase in acetylcholine release in vivo from striata of freely moving rats. Brain Res 1995;589:33-8.
120. Mazarati AM, Halaszi E, Telegdy G. Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in rats. Brain Res 1992;589:164-6.
121. Bloch GJ, Butler PC, Kohlert JG, Bloch DA. Microinjection of galanin into the medial preoptic nucleus facilitates copulatory behavior in the male rat. Physiol Behav 1993;54:615-24.
122. Bloch GJ, Butler PC, Kohlert JG. Galanin microinjected into the medial preoptic nucleus facilitates female- and male-typical sexual behaviors in the female rat. Physiol Behav 1996;59:1147-54.
123. Tsuda K, Tsuda S, Masuyama Y, Goldstein M. Modulation of norepinephrine release by galanin in rat medulla oblongata. Hypertension 1992;20:361-6.
124. Seutin V, Verbanck P, Massotte L, Dresse A. Galanin decreases the activity of locus coeruleus neurons in vitro. Eur J Pharmacol 1989;164:373-6.
125. Sevcik J, Finta EP, Illes P. Galanin receptors inhibit the spontaneous firing of locus coeruleus neurones and interact with μ-opiate receptors. Eur J Pharmacol 1993;230:223-30.
126. Tempel DL, Leibowitz KJ, Leibowitz SF. Effects of PVN galanin on macronutrient selection. Peptidcs 1988;9:309-14.
127. Crawley JN, Austin MC, Fiske SM, Martin B, Consolo S, Berthold M, et al. Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus. J Neurosci 1990;10:3695-700.
128. Kyrkouli SE, Stanley BG, Seirafi RD, Leibowitz SF. Stimulation of feeding by galanin: anatomical localization and behavioral specificity of this peptide's effects in the brain. Peptides 1990;11:995-1001.
129. Bray GA. Peptides affect the intake of specific nutrients and the sympathetic nervous system. Am J Clin Nutr 1992;55:265S-71S.
130. Bray GA. The nutrient balance hypothesis: peptides, sympathetic activity, and food intake. Ann N Y Acad Scii 1993;676:223-41.
131. Leibowitz SF, Kim T. Impact of a galanin antagonist on exogenous galanin and natural patterns of fat ingestion. Brain Res 1992;599:148-52.
132. Corwin RL, Robinson JK, Crawley JN. Galanin antagonists block galanin-induced feeding in the hypothalamus and amygdala of the rat. Eur J Neurosci 1993;5:1528-33.
133. Akabayashi A, Koenig JI, Watanabe Y, Alexander JT, Leibowitz SF. Galanin-containing neurons in the paraventricular nucleus: a neurochemical marker for fat ingestion and body weight gain. Proc Natl Acad Sci U S A 1994;91:10375-9.
134. Leibowitz SF. Specificity of hypothalamic peptides in the control of behavioral and physiological processes. Ann N Y Acad Sci 1994;739:12-35.
135. Leibowitz SF. Brain peptides and obesity: pharmacologic treatment. Obes Res 1995;3(Suppl 4):573S-89S.
136. Smith BK, York DA, Bray GA. Chronic cerebroventricular galanin does not induce sustained hyperphagia or obesity. Peptides 1994;15:1267-72.
137. Melander T, Bartfai T, Brynne N, Consolo S, Fisone G, Hökfelt T, et al. Galanin in the cholinergic basal forebrain: histochemical, autoradiographic and in vivo studies. Prog Brain Res 1989;79:85-91.
138. Crawley JN. Galinin-acetylcholine interactions: relevance to memory and Alzheimer's disease [review]. Life Sci 1996;58:2185-99.
139. Fisone G, Wu CF, Consolo S, Nordström Ö, Brynne N, Bartfai T, et al. Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies. Proc Natl Acad Sci U S A 1987;4:7339-43.
140. Fisone G, Bartfai T, Nilsson S, Hökfelt T. Galanin inhibits the potassium-evoked release of acetylcholine and the muscarinic receptor-mediated stimulation of phosphoinositide turnover in slices of monkey hippocampus. Brain Res 1991;568:279-84.
141. Fisone G, Berthold M, Bedecs K, Unden A, Bartfai T, Bertorelli R, et al. N-terminal galanin-(1-16) fragment is an agonist at the hippocampal galanin receptor. Proc Natl Acad Sci U S A 1989;86:9588-91.
142. Bartfai T, Bedecs K, Land T, Langel Ü, Bertorelli R, Girotti P, et al. M-15: high-affinity chimeric peptide that blocks the neu-ronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord. Proc Natl Acad Sci U S A 1991;88:10961-5.
143. Consolo S, Bertorelli R, Girotti P, La Porta C, Bartfai T, Parenti M, et al. Pertussis toxin-sensitive G-protein mediates galanin's inhibition of scopolamine-evoked acetylcholine release in vivo and carbachol-stimulated phosphoinositide turnover in rat ventral hippocampus. Neurosci Lett 1991;126:29-32.
144. Girotti P, Bertorelli R, Fisone G, Land T, Langel U, Consolo S, et al. N-terminal galanin fragments inhibit the hippocampal release of acetylcholine in vivo. Brain Res 1993;28;612(1-2):258-62.
145. Robinson JK, Zocchi A, Pert A, Crawley JN. Galanin microinjected into the medial septum inhibits scopolamine-induced acetylcholine overflow in the rat ventral hippocampus. Brain Res 1996;709:81-7.
146. Dutar P, Lamour Y, Nicoll RA. Galanin blocks the slow cholinergic EPSP in CA1 pyramidal neurons from ventral hippocampus. Eur J Pharmacol 1989;164:355-60.
147. Palazzi E, Fisone G, Hökfelt T, Bartfai T, Consolo S. Galanin inhibits the muscarinic stimulation of phosphoinositide turnover in rat ventral hippocampus. Eur J Pharmacol 1988;148:479-80.
148. Palazzi E, Felinska S, Zambelli M, Fisone G, Bartfai T, Consolo S. Galanin reduces carbachol stimulation of phosphoinositide turnover in rat ventral hippocampus by lowering Ca2+ influx through voltage-sensitive Ca2+ channels. J Neurochem 1991;56:739-47.
149. Hökfelt T, Millhorn D, Seroogy K, Tsuruo Y, Cecatelli S, Lindh B, et al. Coexistence of peptides with classical neurotransmitters. Experientia 1987;43:768-80.
150. Tomlinson BE, Kitchener D. Granulovacuolar degeneration of hippocampal pyramidal cells. J Pathol 1972;10:165-85.
151. Ball MJ. Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. A quantitative study. Acta Neuropathol 1978;42:73-80.
152. Richter JA, Perry EK, Tomlinson BE. Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer's disease. Life Sci 1980;26:1683-9.
153. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982;215:1237-9.
154. Coyle JT, Price DL, DeLong MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983;219:1184-90.
155. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-70.
156. Van Hoesen GW, Hyman BT. Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Prog Brain Res 1990;83:445-57.
157. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59.
158. Chan-Palay V. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J Comp Neurol 1988;273:543-57.
159. Chan-Palay V. Hyperinnervation of surviving neurons of the human basal nucleus of Meynert by galanin in dementias of Alzheimer's and Parkinson's disease. Adv Neurol 1990;51:253-5.
160. Beal MF, MacGarvey U, Swartz KJ. Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease. Ann Neurol 1990;28:157-61.
161. Mufson EJ, Cochran E, Benzing WC, Kordower JH. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and the bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. Dementia 1993;4:237-50.
162. Minami M, Makino Y, Arai H, lizuka R. A disorganized increase of galanin-like immunoreactivity in cerebral cortex of Alzheimer-type dementia brains. J Neuro Trans Park Dis Dement Sect 1991;3:285-92.
163. Gabriel SM, Bierer LM, Davidson M, Bushyant PP, Perl DP, Haroutunian V. Galanin-like immunoreactivity is increased in the postmortem cerebral cortex from patients with Alzheimer's disease. J Neurochem 1994;62:1516-23.
164. 125]galanin binding sites despite loss of cholinergic neurones to the hippocampus in Alzheimer's disease. Brain Res 1991;568:303-6.
165. Leverenz JB, Raskind MA, Miller MA. Autoradiographic study of galanin binding in the normal and Alzheimer's disease brain: Evidence for increased receptor occupancy in Alzheimer's disease. Abstr Soc Neurosci 1996;22:204.
166. 125I-galanin binding sites in Alzheimer's disease: Increases in hippocampal subfields and a decrease in the caudate nucleus. J Neurochem 1997;68:1106-13.
167. Ikeda M, Dewar D, McCulloch J. Galanin receptor binding sites in the temporal and occipital cortex are minimally affected in Alzheimer's disease. Neurosci Lett 1995;192:37-40.
168. Consolo S, Baldi G, Russi G, Civenni G, Bartfai T, Vezzani A. Impulse flow dependency of galanin release in vivo in the rat ventral hippocampus. Proc Natl Acad Sci U S A 1994;91:8047-51.
169. Vogels OJ, Renkawek K, Broere CA, ter Laak HJ, van Workum F. Galanin-like immunoreactivity within Ch2 neurons in the vertical limb of the diagonal band of Broca in aging and Alzheimer's disease. Acta Neuropathol (Berl) 1989;78:90-5.
170. Liu S, Lyeth BG, Hamm RJ. Protective effect of galanin on behavioral deficits in experimental traumatic brain injury. J Neurotrauma 1994;11:73-82.
171. Mufson EJ, Benzing WC, Kordower JH. Dissociation of galaninergic and neurotrophic plasticity in Down syndrome and Alzheimer's disease. Prog Clin Biol Res 1995;393:105-22.
172. Perry EK, Perry RH, Tomlinson BE. Dietary lecithin supplements in dementia of Alzheimer's type [letter]. Lancet 1977;2:242-3.
173. Smith CM, Swash M. Possible biochemical basis of memory disorder in Alzheimer's disease. Ann Neurol 1978;3:471-3.
174. Perry EK. The cholinergic system in old age and Alzheimer's disease. Age Ageing 1980;9:1-8.
175. Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982;217:408-14.
176. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ 1978;2:1457-9.
177. Perry EK, Blessed G, Tomlinson BE, Perry RH, Crow TJ, Cross AJ, et al. Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes. Neurobiol Aging 1981;2:251-6.
178. Davis BM, Mohs RC, Greenwald BS, Mathe AA, Johns CA, Horvath TB, et al. Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studies. J Am Geriatr Soc 1985;33:741-8.
179. Wester P, Eriksson S, Forsell A, Puu G, Adolfsson R. Monoamine metabolite concentrations and cholinesterase activities in cerebrospinal fluid of progressive dementia patients: relation to clinical parameters. Acta Neurol Scand 1988;77:12-21.
180. Dournaud P, Delaere P, Hauw JJ, Epelbaum J. Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's disease. Neurobiol Aging 1995;16:817-23.
181. Goodnick P, Gershon S. Chemotherapy of cognitive disorders in geriatric subjects. J Clin Psychiatry 1984;45:196-209.
182. Davidson M, Stern RG, Bierer LM, Horvath TB, Zemishlani Z, Markofsky R, et al. Cholinergic strategies in the treatment of Alzheimer's disease. Acta Psychiatr Scand Snppl 1991;366:47-51.
183. Decker MW. Animal models of cognitive function. Crit Rev Neurobiol 1995;9:321-43.
184. Sarter M, Bruno JP, Dudchenko P. Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification. Psychopharmacology 1990;101:1-17.
185. Unger JW, Schmidt Y. Galanin-immunoreactivity in the nucleus basalis of Meynert in the rat: age-related changes and differential response to lesion-induced cholinergic cell loss. Neurosci Lett 1993;153:140-3.
186. Senut MC, de Bilbao F, Lamour Y. Age-related loss of galanin-immunoreactive cells in the rat septal area. Neurosci Lett 1989;105:257-62.
187. de Bilbao F, Senut M-C, Sweeney J, Jazat F, Lamour Y. Étude comparative chez le rat âgé des déficits comportementaux et des modifications morphométriques des neurones contenant de la galanine dans la région septale médiane. [Comparative study in aged rats of behavioural deficiencies and morphometrical modifications of galanin containing neurons in the medial septal area.] C R Acad Sci III 1991;312:503-9.
188. Krzywkowski P, Lagny-Pourmir I, Jazat F, Lamour Y, Epelbaum J. The age-related increase in galanin binding sites in the rat brain correlates with behavioral impairment. Neuroscience 1994;59:599-607.
189. de Bilbao F, Jazat F, Lamour Y, Senut MC. Age-related changes in galanin-immunoreactive cells of the rat medial septal area. J Comp Neurol 1991;313:613-24.
190. Dunnett SB, Everitt BJ, Robbins TW. The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci 1991;14:494-501.
191. Jarrard LE. On the role of the hippocampus in learning and memory in the rat. Behav Neural Biol 1993;60:9-26.
192. Melander T, Staines WA, Rökaeus Å. Galanin-like immunoreactivity in hippocampal afferents in the rat, with special reference to cholinergic and noradrenergic inputs. Neuroscience 1986;19:223-40.
193. Wenk GL, Rökaeus Å. Basal forebrain lesions differentially alter galanin levels and acetylcholinergic receptors in the hippocampus and neocortex. Brain Res 1988;460:17-21.
194. Beal MF, Clevens RA, Chattha GK, MacGarvey UM, Mazurek MF, Gabriel SM. Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex. J Neurochem 1988;51:1935-41.
195. Cortes R, Villar MJ, Verhofstad A, Hökfelt T. Effects of central nervous system lesions on the expression of galanin: a comparative in situ hybridization and immunohistochemical study. Proc Natl Acad Sci U S A 1990;87:7742-6.
196. Agoston DV, Komoly S, Palkovits M. Selective up-regulation of neuropeptide synthesis by blocking the neuronal activity: galanin expression in septohippocampal neurons. Exp Neurol 1994;126:247-55.
197. de Lacalle S, Kulkarni S, Mufson EJ. Plasticity of galaninergic fibers following neurotoxic damage within the rat basal forebrain: initial observations. Exp Neurol 1997;146:361-6.
198. Wenk GL, Stoehr JD, Quintana G, Mobley S, Wiley RG. Behavioral, biochemical, histological, and electrophysiological effects of 192IgG saporin injections into the basal forebrain of rats. J Neurosci 1994;14:5986-95.
199. Harrington CA, Mobley SL, Wenk GL. Nitric oxide formation does not underlie the memory deficits produced by ibotenate injections into the nucleus basalis of rats. Behav Neurosci 1994;108:277-83.
200. Robinson JK, Crawley JN. The role of galanin in cholinergically-mediated processes. Prog Neuropsychopharm Biol Psychiatry 1993;17:71-85.
201. Crawley JN, Wenk GL. Co-existence of galanin and acetylcholine: is galanin involved in memory processes and dementia? Trends Neurosci 1989;21:278-82.
202. Crawley JN. Functional interactions of galanin and acetylcholine: relevance to memory and Alzheimer's disease. Behav Brain Res 1993;57:133-41.
203. Robinson JK, Crawley JN. Intraventricular galanin impairs delayed nonmatching-to-sample performance in rats. Behav Neu rosci 1993;107:458-67.
204. Robinson JK, Crawley JN. Analysis of anatomical sites at which galanin impairs delayed nonmatching to sample. Behav Neurosci 1994;108:941-50.
205. McDonald MP, Crawley JN. Galanin receptor antagonist M40 blocks galanin-induced choice accuracy deficits on a delayed-nonmatching-to-position task. Behav Neurosci 1996;110:1025-32.
206. Flicker C, Bartus RT, Crook TH, Ferris S H. Effects of aging and dementia upon recent visuospatial memory. Neurobiol Aging 1984;5:275-83.
207. Flicker C, Dean R, Bartus RT, Ferris SH, Crook T. Animal and human memory dysfunctions associated with aging, cholinergic lesions, and senile dementia. Ann N Y Acad Sci 1985;444:515-7.
208. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991;41:1006-9.
209. Flicker C, Ferris SH, Reisberg B. A two-year longitudinal study of cognitive function in normal aging and Alzheimer's disease. J Geriatr Psychiatry Neurol 1993;6:84-96.
210. Flicker C, Ferris SH, Kalkstein D, Serby M. A double-blind, placebo-controlled crossover study of ganglioside GM1 treatment for Alzheimer's disease. Am J Psychiatry 1994;151:126-9.
211. Sahakian BJ, Morris RG, Evenden JL, Heald A, Levy R, Philpot M, et al. A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain 1988;11:695-718.
212. Abas MA, Sahakian BJ, Levy R. Neuropsychological deficits and CT scan changes in elderly depressives. Psychol Med 1990;20:507-20.
213. Smith G. Animal models of Alzheimer's disease: experimental cholinergic denervation. Brain Res Rev 1988;13:103-18.
214. Money EA, Kirk RC, McNaughton N. Alzheimer's dementia produces a loss of discrimination but no increase in rate of memory decay in delayed matching to sample. Neuropsychologia 1992;30:133-43.
215. Sahgal A, Keith AB. Combined serotonergic-cholinergic lesions do not disrupt memory in rats. Pharmacol Biochem Behav 1993;45:995-1001.
216. Robinson JK, Crawley JN. Intraseptal galanin potentiates scopolamine impairment of delayed nonmatching to sample. J Neurosci 1993;13:5119-25.
217. Givens B, Olton DS, Crawley JN. Galanin in the medial septal area impairs working memory. Brain Res 1992;582:71-77.
218. Mastropaolo J, Nadi N, Ostrowski NL, Crawley JN. Galanin antagonizes acetylcholine on a memory task in basal forebrain-lesioned rats. Proc Natl Acad Sci U S A 1988;85:9841-45.
219. Malin DH, Novy BJ, Lett-Brown A, Plotner RE, May BT, Radulescu SJ, et al. Galanin attenuates retention of one-trial reward learning. Life Sci 1992;50:939-44.
220. Sundstrom E, Archer T, Melander T, Hökfelt T. Galanin impairs acquisition but not retrieval of spatial memory in rats studied in the Morris swim maze. Neurosci Lett 1988;88:331-5.
221. Aspley S, Fone KC. Galanin fails to alter both acquisition of a two trial per day water maze task and neurochemical markers of cholinergic or serotonergic neurones in adult rats. Brain Res 1993;622:330-6.
222. Kameyama T, Ukai M, Miura M. Dynorphin A-(1-13) potently improves galanin-induced impairment of memory processes in mice. Neuropharmacology 1994;33:1167-9.
223. Ukai M, Miura M, Kameyama T. Effects of galanin on passive avoidance response, elevated plus-maze learning, and spontaneous alternation performance in mice. Peptides 1995;16:1283-6.
224. Bartfai T, Fisone G, Langel Ü. Galanin and galanin antagonists: molecular and biochemical perspectives. Trends Pharmacol Sci 1992;13:312-7.
225. Langel Ü, Land T, Bartfai T. Design of chimeric peptide ligands to galanin receptors and substance P receptors, Int J Pept Protein Res 1992;39:516-22.
226. Bartfai T. Galanin: A neuropeptide with important central nervous system actions. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995.
227. Gregersen S, Lindskog S, Land T, Langel Ü, Bartfai T, Ahrén B. Blockade of galanin-induced inhibition of insulin secretion from isolated mouse islets by the non-methionine containing antagonist M35. Eur J Pharmacol 1993;232:35-9.
228. Ögren SO, Pramanik A, Land T, Langel Ü. Differential effects of the putative galanin receptor antagonists M15 and M35 on striatal acetylcholine release. Eur J Pharmacol 1993;242:59-64.
229. Arvidsson K, Land T, Langel U, Bartfai T, Ehrenberg A. Solution structure by 2D 1H-NMR of a chimeric peptide recognized by galanin and neuropeptide Y receptors. Biochemistry 1993;32:7787-98.
230. Arvidsson K, Langel U, Ehrenberg A. Comparison of the solution structures of the chimeric peptides galanin(1-12)-Ala-neuropeptide Y(25-36)amide and galanin(1-12)-Pro-neuropeptide Y(25-36)amide. Eur J Biochem 1994;222:573-81.
231. Hedlund PB, Finnman UB, Yanaihara N, Fuxe K. Galanin-(1-15), but not galanin-(1-29), modulates 5-HT1A receptors in the dorsal hippocampus of the rat brain: possible existence of galanin receptor subtypes. Brain Res 1994;634:163-7.
232. Ohman A, Lycksell PO, Andell S, Langel U, Bartfai T, Graslund A. Solvent stabilized solution structures of galanin and galanin analogs, studied by circular dichroism spectroscopy. Biochim Biophys Acta 1995;1236:259-65.
233. Kakuyama H, Mochizuki T, Iguchi K, Yamabe K, Hosoe H, Hoshino M, et al. [Ala6, D-Trp8]galanin(1-15)ol is a potent galanin antagonist on insulin release. Biomed Res 1997;18:49-56.
234. Lorinet AM, Javoy-Agid F, Laburthe M, Amiranoff B. Galanin receptors in human hypothalamus: biochemical and structural analysis. Eur J Pharmacol 1994;269:59-64.
235. Fridolf T, Ahrén B. Dual action of the neuropeptide galanin on the cytoplasmic free calcium concentration in RIN m5F cells. Biochem Biophys Res Commun 1993;191:1224-29.
236. Patel S, Hutson PH. Hypothermia induced by cholinomimetic drugs is blocked by galanin: possible involvement of ATP-sensitive K+ channels. Eur J Pharmacol 1994;255:25-32.
237. Amoroso D, Girotti P, Fisone G, Bartfai T, Console S. Mechanism of the galanin induced increase in acetylcholine release in vivo from striata of freely moving rats. Brain Res 1992;589:33-8.
238. Pramanik A, Ögren SO. Galanin stimulates striatal acetylcholine release via a mechanism unrelated to cholinergic receptor stimulation. Regul Pept 1993;45:353-62.
239. Crawley JN, Robinson JK, Langel Ü, Bartfai T. Galanin receptor antagonists M40 and C7 block galanin-induced feeding. Brain Res 1993;600:268-72.
240. Corwin RL, Rowe PM, Crawley JN. Galanin and the galanin antagonist M40 do not change fat intake in a fat-chow choice paradigm in rats. Am J Physiol 1995;269:R511-8.
241. de Pedro N, Cespedes MV, Delgado MJ, Alonso-Bedate M. The galanin-induced feeding stimulation is mediated via alpha 2-adrenergic receptors in goldfish. Regul Pept 1995;57:77-84.
242. Benelli A, Arletti R, Bertolini A, Menozzi B, Basaglia R, Poggioli R. Galantide stimulates sexual behaviour in male rats. Eur J Pharmacol 1994;260:279-82.
243. Ögren SO, Hökfelt T, Kask K, Langel Ü, Bartfai T. Evidence for a role of the neuropeptide galanin in spatial learning. Neuroscience 1992;51:1-5.
244. Gu ZF, Rossowski WJ, Coy DH, Pradhan TK, Jensen RT. Chimeric galanin analogs that function as antagonists in the CNS are full agonists in gastrointestinal smooth muscle. J Pharmacol Exp Ther 1993;266:912-8.
245. Kask K, Berthold M, Bourne J, Andell S, Langel Ü, Bartfai T. Binding and agonist/antagonist actions of M35, galanin(1-13)-bradykinin(2-9)amide chimeric peptide, in Rin m 5F insulinoma cells. Regul Pept 1995;59:341-8.
246. Heuillet E, Bouaiche Z, Menager J, Dugay P, Munoz N, Dubois H, et al. The human galanin receptor: ligand-binding and functional characteristics in the Bowes melanoma cell line. Eur J Pharmacol 1994;269:139-47.